Predictive Value of Computed Tomography Characteristics for Nivolumab Response in Pretreated Non-Small Cell Lung Cancer

被引：0
|
作者：
Imai, H. [1 ]
Minemura, H. [2 ]
Moriya, H. [3 ]
Sugiyama, T. [4 ]
Yamada, Y. [5 ]
Higuchi, M. [6 ]
Kaira, K. [7 ]
Ozaki, Y. [8 ]
Kanazawa, K. [2 ]
Yokouchi, H. [9 ]
Kasai, T. [4 ]
Kaburagi, T. [5 ]
Suzuki, H. [8 ]
Minato, K. [1 ]
Shibata, Y. [2 ]
机构：
[1] Gunma Prefectural Canc Ctr, Div Resp Med, Ota, Gunma, Japan
[2] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan
[3] Ohara Gen Hosp, Diagnost Imaging Ctr, Fukushima, Japan
[4] Tochigi Canc Ctr, Div Thorac Oncol, Utsunomiya, Tochigi, Japan
[5] Ibaraki Prefctural Cent Hosp & Canc Ctr, Resp Med, Ibaraki, Japan
[6] Fukushima Med Univ, Dept Surg, Aizu Med Ctr, Fukushima, Japan
[7] Saitama Med Univ, Dept Resp Med, Int Med Ctr, Saitama, Japan
[8] Fukushima Med Univ, Sch Med, Dept Chest Surg, Fukushima, Japan
[9] Natl Hosp Org Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
non-small cell lung cancer; immune check point inhibitor; Morphologic characteristics;
D O I：
10.1016/j.jtho.2018.08.1603
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-43
引用
收藏
页码：S883 / S884
页数：2
相关论文
共 50 条
  • [31] Nivolumab, a new hope in non-small cell lung cancer
    Flippot, Ronan
    Fallet, Vincent
    Besse, Benjamin
    Massard, Christophe
    Wislez, Marie
    Vignot, Stephane
    BULLETIN DU CANCER, 2015, 102 (12) : 1046 - 1052
  • [32] Nivolumab in a patient with HIV and non-small cell lung cancer
    Hentrich, M.
    Schipek-Voigt, K.
    Jaeger, H.
    Schulz, S.
    Schmid, P.
    Stoetzer, O.
    Bojko, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 232 - 232
  • [33] Nivolumab plus chemotherapy for non-small cell lung cancer
    Lichert, Frank
    PNEUMOLOGIE, 2024, 78 (02): : 81 - 81
  • [34] Biomarkers predictive value in early stage non-small cell lung cancer
    Malapelle, Umberto
    Vigliar, Elena
    Troncone, Giancarlo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 956 - 959
  • [35] Prognostic and predictive value of MET deregulation in non-small cell lung cancer
    Finocchiaro, Giovanna
    Toschi, Luca
    Gianoncelli, Letizia
    Baretti, Marina
    Santoro, Armando
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (06)
  • [36] FDG-PET response to nivolumab is predictive of tumor progression and survival in non-small cell lung cancer patients
    Seraj, Siavash Mehdizadeh
    Zadeh, Mandi Zirakchian
    Jahangiri, Pegah
    Kaghazchi, Fatemeh
    Kalboush, Eman
    Werner, Thomas
    Newberg, Andrew
    Hunt, Stephen
    Alavi, Abass
    Revheim, Mona-Elisabeth
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [37] Combination of nivolumab with radiotherapy for non-small cell lung cancer
    Cihan, Y. B.
    ARCHIVES OF HELLENIC MEDICINE, 2022, 39 (06): : 857 - 858
  • [38] Computed Tomography lung texture changes due to radiotherapy for non-small cell lung cancer
    Chalubinska-Fendler, J.
    Fendler, W.
    Karolczak, L.
    Chudobinski, C.
    Luniewska-Bury, J.
    Materka, A.
    Fijuth, J.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S873 - S874
  • [39] Optimal Combination of Biomarkers to Improve the Predictive Value of Immunotherapeutic Response in Non-Small Cell Lung Cancer
    Kwon, S.
    Kwon, H. J.
    Kim, E. S.
    Suh, K. J.
    Kim, S. H.
    Kim, Y. J.
    Lee, J.
    Chung, J.
    Kim, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S333 - S334
  • [40] The value of positron emission tomography in patients with non-small cell lung cancer
    Kee, Frank
    Erridge, Sara
    Bradbury, Ian
    Cairns, Karen
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 73 (01) : 50 - 58
12345